In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures
Autor: | Barry Bohnet, Brian A. MacVicar, Terrance P. Snutch, Andrew Yung, John R. Tyson, Jeffrey M. LeDue, Huili Han, Esperanza Garcia, Piotr Kozlowski, Sascha R.A. Alles, Stuart M. Cain, Arn M. J. M. van den Maagdenberg |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Cerebellar Ataxia Migraine Disorders Migraine with Aura Pregabalin Gene Expression Mice Transgenic Pharmacology Neurotransmission Synaptic Transmission familial hemiplegic migraine type 1 03 medical and health sciences Mice 0302 clinical medicine Calcium Channels N-Type In vivo Commentaries medicine Edema Animals Humans migraine Familial hemiplegic migraine Cerebral Cortex Neurons Analgesics Multidisciplinary business.industry Calcium channel Cortical Spreading Depression Brain gabapentinoids Biological Sciences medicine.disease Calcium Channel Blockers diffusion-weighted MRI 3. Good health Disease Models Animal 030104 developmental biology Diffusion Magnetic Resonance Imaging Migraine Cortical spreading depression Mutation Systemic administration business voltage-gated calcium channel 030217 neurology & neurosurgery medicine.drug |
Zdroj: | Proceedings of the National Academy of Sciences, 114(9), 2401-2406 Proceedings of the National Academy of Sciences |
Popis: | Migraine is characterized by severe headaches that can be preceded by an aura likely caused by cortical spreading depression (SD). The antiepileptic pregabalin (Lyrica) shows clinical promise for migraine therapy, although its efficacy and mechanism of action are unclear. As detected by diffusion-weighted MRI (DW-MRI) in wild-type (WT) mice, the acute systemic administration of pregabalin increased the threshold for SD initiation in vivo. In familial hemiplegic migraine type 1 mutant mice expressing human mutations (R192Q and S218L) in the CaV2.1 (P/Q-type) calcium channel subunit, pregabalin slowed the speed of SD propagation in vivo. Acute systemic administration of pregabalin in vivo also selectively prevented the migration of SD into subcortical striatal and hippocampal regions in the R192Q strain that exhibits a milder phenotype and gain of CaV2.1 channel function. At the cellular level, pregabalin inhibited glutamatergic synaptic transmission differentially in WT, R192Q, and S218L mice. The study describes a DW-MRI analysis method for tracking the progression of SD and provides support and a mechanism of action for pregabalin as a possible effective therapy in the treatment of migraine. |
Databáze: | OpenAIRE |
Externí odkaz: |